Nanalysis Upsizes Private Placement After Closing First $2.5 Million Tranche

Nanalysis Scientific ( (TSE:NSCI) ) has shared an announcement.

Nanalysis Scientific has closed the first tranche of its non-brokered private placement, raising roughly $2.5 million through the issuance of 16.5 million units at $0.15 each, with proceeds earmarked primarily for debt reduction. On the back of strong investor demand, the company has also upsized the offering, planning to issue up to an additional 23.3 million units for potential gross proceeds of $3.5 million, with extra funds to be used for further debt reduction and magnet inventory, while the transaction—subject to TSX Venture Exchange approval—includes standard warrant terms, a small insider subscription treated as a related-party deal under securities rules, and a modest finder’s fee to Haywood Securities.

The most recent analyst rating on (TSE:NSCI) stock is a Buy with a C$0.50 price target. To see the full list of analyst forecasts on Nanalysis Scientific stock, see the TSE:NSCI Stock Forecast page.

More about Nanalysis Scientific

Nanalysis Scientific Corp. develops and manufactures portable Nuclear Magnetic Resonance (NMR) spectrometers used globally across the pharmaceutical, biotech, energy, food, materials and security sectors, as well as in academic and government laboratories. The company also runs a growing services division that maintains both its own and third‑party imaging equipment, anchored by a long-term $160 million contract with the Canadian Air Transport Security Authority to service security scanners at more than 80 Canadian airports.

Average Trading Volume: 116,189

Technical Sentiment Signal: Sell

Current Market Cap: C$18.53M

For detailed information about NSCI stock, go to TipRanks’ Stock Analysis page.